MTCH2 and non-small cell lung carcinoma: Additionally, when combining MTCH2 expression data for LUAD plus LUSC, the ROC analysis yielded an AUC of 0.874 (Fig. 1M), further supporting the potential of MTCH2 overexpression as a diagnostic marker for NSCLC.